Astec LifeSciences (ASTEC) | Stock Overview & Key Data
Astec LifeSciences Performance Comparison
Stock Range
Today's Range
Low: ₹795.00
High: ₹828.80
on August 18, 2025
52 Week Range
Low: ₹634.60
High: ₹1,333.50
on May 9, 2025
on September 24, 2024
All-Time High: ₹2,288.80 on November 14, 2022
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR18.1B
EPS
-64.81
P/E Ratio (TTM)
399.52
Forward P/E
20.05
P/B Ratio
6.77
PEG Ratio
-22.88
Div. Yield
N/A
ROE
-57.34%
Beta
0.060
Debt to Equity
235.96
Financial Highlights
Profitability
Gross Margin
29.86%
Operating Margin
-24.68%
Profit Margin
-31.78%
Returns and Earnings
Return on Assets (TTM)
-15.29%
Return on Equity (TTM)
-57.34%
EBITDA
INR-321.0M
Net Income (TTM)
INR-1.3B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR203.94
Quarterly Revenue Growth (YoY)
31.30%
Quarterly Earnings Growth (YoY)
31.29%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Astec LifeSciences ASTEC | 18.05B Small-cap | -2.46% | -12.92% | 18.26% | -4.29% | -17.65% | -30.00% | -56.78% | -35.28% |
| Coromandel COROMANDEL | 693.75B Large-cap | -3.82% | -1.34% | -2.08% | 34.30% | 22.01% | 33.72% | 128.12% | 195.65% |
| UPL UPLPP | 622.77B Large-cap | 0.00% | 16.86% | 21.84% | 96.43% | 129.00% | 104.96% | 104.96% | 104.96% |
| Bharat Rasayan BHARATRAS | 45.78B Small-cap | 4.38% | -2.48% | 15.86% | 9.81% | 8.75% | -15.72% | -8.92% | 12.93% |
| National Fertilizers NFL | 45.02B Small-cap | -1.09% | -5.19% | 1.73% | 7.02% | -22.84% | -30.74% | 88.25% | 144.39% |
| Mangalore Chemicals MANGCHEFER | 40.69B Small-cap | -2.42% | 24.02% | 43.66% | 123.74% | 113.79% | 156.77% | 177.98% | 883.67% |
Ownership & Short Interest
Insider Ownership
83.86%
Institutional Ownership
6.81%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
77K
Average 90-Day Volume
52K
Astec LifeSciences Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Astec LifeSciences would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ASTEC's 52-week high and low?
- In the last 52 weeks, Astec LifeSciences reached a high of ₹1,333.50 (on September 24, 2024) and a low of ₹634.60 (on May 9, 2025).
- What is the market cap and P/E ratio for ASTEC?
- Curious about Astec LifeSciences's size and valuation? Its market capitalization stands at 18.05B. When it comes to valuation, the P/E ratio (trailing twelve months) is 399.52, and the forward P/E (looking ahead) is 20.05.
- Does ASTEC pay dividends? If so, what's the yield?
- As for dividends, Astec LifeSciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Astec LifeSciences's main competitors or similar companies to consider before investing?
When looking at Astec LifeSciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Coromandel
COROMANDEL693.75B Basic Materials Agricultural Inputs 33.72% 128.12% UPL
UPLPP622.77B Basic Materials Agricultural Inputs 104.96% 104.96% Bharat Rasayan
BHARATRAS45.78B Basic Materials Agricultural Inputs -15.72% -8.92% National Fertilizers
NFL45.02B Basic Materials Agricultural Inputs -30.74% 88.25% Mangalore Chemicals
MANGCHEFER40.69B Basic Materials Agricultural Inputs 156.77% 177.98% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Astec LifeSciences Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Astec LifeSciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -57.34%, the Debt to Equity ratio from the most recent quarter is 235.96, and its Gross Profit Margin stands at 29.86%.
- What is the recent revenue and earnings growth for ASTEC?
- Looking at Astec LifeSciences's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 31.30%, and quarterly earnings saw a YoY growth of 31.29%.
- How much of ASTEC stock is held by insiders and institutions?
- Wondering who owns Astec LifeSciences stock? Company insiders (like executives and directors) hold about 83.86% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 6.81%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.